Growth Metrics

Avadel Pharmaceuticals (AVDL) Asset Utilization Ratio: 2009-2020

Historic Asset Utilization Ratio for Avadel Pharmaceuticals (AVDL) over the last 9 years, with Dec 2020 value amounting to 0.05.

  • Avadel Pharmaceuticals' Asset Utilization Ratio fell 87.20% to 0.05 in Q4 2020 from the same period last year, while for Dec 2020 it was 0.05, marking a year-over-year decrease of 87.20%. This contributed to the annual value of 0.10 for FY2020, which is 72.17% down from last year.
  • Latest data reveals that Avadel Pharmaceuticals reported Asset Utilization Ratio of 0.05 as of Q4 2020, which was down 45.12% from 0.09 recorded in Q3 2020.
  • In the past 5 years, Avadel Pharmaceuticals' Asset Utilization Ratio ranged from a high of 0.68 in Q3 2017 and a low of 0.05 during Q4 2020.
  • In the last 3 years, Avadel Pharmaceuticals' Asset Utilization Ratio had a median value of 0.42 in 2018 and averaged 0.35.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first soared by 101.92% in 2017, then crashed by 87.20% in 2020.
  • Avadel Pharmaceuticals' Asset Utilization Ratio (Quarterly) stood at 0.61 in 2016, then grew by 7.71% to 0.66 in 2017, then crashed by 31.44% to 0.45 in 2018, then fell by 14.30% to 0.39 in 2019, then crashed by 87.20% to 0.05 in 2020.
  • Its last three reported values are 0.05 in Q4 2020, 0.09 for Q3 2020, and 0.17 during Q2 2020.